CVS Health Corporation $CVS Shares Sold by Resona Asset Management Co. Ltd.

Resona Asset Management Co. Ltd. reduced its stake in shares of CVS Health Corporation (NYSE:CVS) by 4.0% during the 4th quarter, Holdings Channel.com reports. The firm owned 409,199 shares of the pharmacy operator’s stock after selling 17,191 shares during the quarter. Resona Asset Management Co. Ltd.’s holdings in CVS Health were worth $32,519,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently modified their holdings of CVS. McKinley Carter Wealth Services Inc. purchased a new position in CVS Health in the 4th quarter worth approximately $203,000. Profund Advisors LLC increased its stake in CVS Health by 26.1% during the fourth quarter. Profund Advisors LLC now owns 20,651 shares of the pharmacy operator’s stock worth $1,639,000 after acquiring an additional 4,279 shares during the last quarter. ProShare Advisors LLC increased its holdings in CVS Health by 7.7% in the 4th quarter. ProShare Advisors LLC now owns 264,715 shares of the pharmacy operator’s stock valued at $21,008,000 after purchasing an additional 19,018 shares during the last quarter. HighTower Advisors LLC increased its holdings in CVS Health by 3.7% in the 4th quarter. HighTower Advisors LLC now owns 276,039 shares of the pharmacy operator’s stock valued at $21,906,000 after purchasing an additional 9,726 shares during the last quarter. Finally, Envestnet Portfolio Solutions Inc. increased its holdings in CVS Health by 1.6% in the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 51,895 shares of the pharmacy operator’s stock valued at $4,118,000 after purchasing an additional 806 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at CVS Health

In other CVS Health news, EVP Tilak Mandadi sold 69,551 shares of CVS Health stock in a transaction on Friday, May 8th. The shares were sold at an average price of $89.58, for a total value of $6,230,378.58. Following the transaction, the executive vice president owned 10,133 shares in the company, valued at $907,714.14. This trade represents a 87.28% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.85% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. Deutsche Bank Aktiengesellschaft boosted their price target on shares of CVS Health from $88.00 to $92.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Leerink Partners restated an “outperform” rating and issued a $98.00 price objective on shares of CVS Health in a research note on Thursday, March 5th. UBS Group increased their target price on shares of CVS Health from $97.00 to $100.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. Wolfe Research decreased their target price on shares of CVS Health from $100.00 to $97.00 and set an “outperform” rating for the company in a research note on Monday, March 2nd. Finally, The Goldman Sachs Group increased their price target on shares of CVS Health from $95.00 to $97.00 and gave the stock a “buy” rating in a report on Thursday, February 12th. Twenty-two research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $98.08.

CVS Health Trading Down 1.9%

Shares of CVS Health stock opened at $94.18 on Wednesday. CVS Health Corporation has a 12-month low of $58.50 and a 12-month high of $98.43. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.78. The stock has a market cap of $120.16 billion, a PE ratio of 41.49, a price-to-earnings-growth ratio of 0.94 and a beta of 0.60. The company has a 50-day moving average of $79.39 and a two-hundred day moving average of $78.76.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share for the quarter, topping analysts’ consensus estimates of $2.21 by $0.36. CVS Health had a net margin of 0.72% and a return on equity of 11.88%. The business had revenue of $100.43 billion during the quarter, compared to analysts’ expectations of $94.99 billion. During the same period last year, the company posted $2.25 EPS. The company’s revenue was up 6.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. On average, research analysts anticipate that CVS Health Corporation will post 7.44 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, May 4th. Investors of record on Thursday, April 23rd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, April 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.8%. CVS Health’s dividend payout ratio (DPR) is 117.18%.

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS Health and WGU launched an online pre-pharmacy degree program aimed at building a pipeline of future pharmacists nationwide, which could help address labor shortages and support CVS’s retail pharmacy operations. CVS Health(R) and WGU Launch Online Pre-Pharmacy Degree Program for Future Pharmacists Nationwide
• Positive Sentiment: CVS also backed EnsembleIQ’s campaign supporting retail pharmacy as a way to help fill healthcare gaps, reinforcing CVS’s role in community pharmacy and care access. EnsembleIQ’s DSN, a Trusted Source in the Community Pharmacy Space, Launches Campaign in Support of Retail Pharmacy Filling Health Care Gaps
• Positive Sentiment: CVS Health published a study showing many Medicare members struggle with digital health literacy, which supports the company’s push to invest in digital tools and member engagement. CVS Health study reveals a need for greater digital health literacy for Medicare members

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.